JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rasey, J. S.
Right arrow Articles by Schwartz, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rasey, J. S.
Right arrow Articles by Schwartz, J. L.

Validation of FLT Uptake as a Measure of Thymidine Kinase-1 Activity in A549 Carcinoma Cells

Janet S. Rasey, PhD1, John R. Grierson, PhD2, Linda W. Wiens, BS1, Pamella D. Kolb, BS1 and Jeffrey L. Schwartz, PhD1

1 Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington
2 Department of Radiology, University of Washington School of Medicine, Seattle, Washington



View larger version (18K):

[in a new window]
 
FIGURE 1. (A) Changes in S phase fraction as function of time after subculturing of growth-arrested A549 cells into fresh culture medium. (B) Uptake of 3H-FLT in A549 cells as function of time after 8-d-old growth-arrested cells were subcultured into fresh growth medium. FLT uptake is expressed relative to activity levels in culture medium. Uptake equal to 100% represents equilibration between cells and medium, whereas higher values mean that cells have concentrated tracer. (C) Uptake of 3H-FLT in A549 cells versus percentage in S phase.

 


View larger version (20K):

[in a new window]
 
FIGURE 2. (A) TK1 activity in A549 cells as function of time. TK1 activity units are picomoles of phosphorylated TdR/30 min/mg of protein, as determined in cell-free enzymatic assay using A549 cell lysate as source of enzyme. (B) Uptake of 3H-FLT in A549 cells versus TK1 activity.

 


View larger version (19K):

[in a new window]
 
FIGURE 3. (A) Changes in S phase fraction versus time after subculturing of growth-arrested A549-LXSN and A549-E6 cells. (B) Uptake of 3H-FLT in A549-E6 and A549-LXSN cells as function of time after 8-d-old growth-arrested cells were subcultured into fresh growth medium. FLT uptake is expressed relative to activity levels in culture medium. Uptake equal to 100% represents equilibration between cells and medium, whereas higher values mean that cells have concentrated tracer.

 


View larger version (18K):

[in a new window]
 
FIGURE 4. (A) Effect of 10-Gy {gamma}-radiation on movement of growth-arrested A549-E6 and A549-LXSN cells into S phase of cell cycle when subcultured into fresh growth medium. Irradiated LXSN cells do not enter cell cycle during first 24 h after being placed into fresh medium. E6-transfected cells, lacking functional p53, begin to enter S phase by 12 h. (B) Uptake of 3H-FLT into irradiated A549-E6 and A549-LXSN cells as function of time after 8-d-old growth-arrested cells were subcultured into fresh growth medium. Cells were irradiated with 10-Gy 137Cs {gamma}-rays immediately before being placed into fresh medium. FLT uptake is expressed relative to activity levels in culture medium, with 100% uptake representing equilibration between cells and medium. Irradiated LXSN cells do not show increased uptake of FLT during first 24 h, consistent with their failure to move into cell cycle (A). (C) TK1 activity in irradiated A549-E6 and A549-LXSN cells as function of time after growth-arrested cells were subcultured into fresh growth medium. Cells were irradiated with 10-Gy 137Cs {gamma}-rays immediately before being placed into fresh medium. TK1 activity does not increase in growth-arrested, irradiated LXSN cells.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.